Molecular Switches: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claim Analysis)

  • Lowest Price Guaranteed From USD 1,899

  • Published
    December 2022

  • Slides
    136

  • View Count
    585

Example Insights

Molecular-switches-IPLandscape-Context-thumb Molecular-switches-IPLandscape-applications-thumb Molecular-switches-IPLandscape-Switches-thumb Molecular-switches-IPLandscape-Diagnostics-thumb
Molecular-switches-IPLandscape-Expressions-thumb Molecular-switches-IPLandscape-parameters-thumb Molecular-switches-IPLandscape-launch-thumb Molecular-switches-IPLandscape-domain-thumb
Molecular-switches-IPLandscape-Claims-thumb Molecular-switches-IPLandscape-Innovations-thumb Molecular-switches-IPLandscape-figures-thumb Molecular-switches-IPLandscape-Deliverable-thumb

Overview

Attempts to synthetically recreate the biological circuits in human body is a relatively new area of research within synthetic biology. Ever since the 2010s, the use of molecular “toggle” switches to mimic electronic circuits has been prevalent to understand, alter, and recreate molecular circuits within the human body. The evolution of chemistry and synthetic biology has reached an interesting point as these complex processes, including genetic regulation, expression, and replication are being understood at a molecular level. The prominent elements of these exploratory studies are molecular switches, which are responsive to internal or external stimuli and can be manipulated to create a transition between two stable states when exposed to a change in their optical, electrical, or chemical environment. During the past few years, several molecules have been identified and characterized as “switches”, which are now available for the construction of complex synthetic signaling networks with applications in both biology and nanotechnology. Of the different types of molecules, organic molecules, including proteins, nucleic acids, and cyclic organic compounds, such as crown ethers are likely to be the promising candidates in this field due to their diverse structural, electrical, and mechanical properties. In addition, synthetic molecules, such as Rotaxanes and Catenanes have emerged as potential molecular switches, as the binding sites within these mechanically interlocked molecules can be manipulated upon the application of stimuli, resulting in a shift in their structure and chemistry on cue.

One of the most important applications of molecular switches is to combat the challenges associated with anticancer therapies, like system toxicity, multidrug resistance, poor solubility, and membrane permeability. In order to overcome these drawbacks, researchers have undertaken several R&D efforts for identifying and developing effective treatment modalities. Among other alternatives, the use of Nanocarriers has emerged as a viable option. These nanomaterials encapsulate the drug, essentially warding it off from the surrounding physiological conditions and minimizing the side effects. Upon installation of molecular switches in their structure, these nanocarriers can be manipulated to gravitate towards a specific environment within the body and release the drug, when stimulated. The stimulus can further be manipulated to obtain the desired dosage strength and frequency. The extent of modification in these molecules allows for the use of minute differences in the biochemistry of different tissues as stimuli for targeted delivery of drugs. Simultaneously, with constant evolution in biomedical research and other emerging fields, such as optogenetics, molecular switches are being explored to directly switch the genes “on” and “off”, leading to control over genetic regulation and expression. The potential of gaining control over the molecular architecture and consequently, molecular function has led to a steady increase in the research and entrepreneurial activity in this domain. As a result, the intellectual capital around compositions of molecular switches, engineering techniques, and their application in gene regulation and therapeutic use, has also grown. In light of such developments, it is important to keep track of both pockets of innovation and key areas of improvement for stakeholders to remain competitive in this upcoming field of medicine / drugs. This report captures some of the key R&D-related trends and provides competitive intelligence on intellectual property in the field of molecular switches.

Scope of the Report

The “Molecular Switches: Intellectual Property Landscape” report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of molecular switch interventions intended to treat a growing range of clinical conditions. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain. Key inclusions are briefly described below:

  • Overall Intellectual Property Landscape

An analytical perspective of the various patents and affiliated IP documents that have been published related to molecular switches, since 1981. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this niche, but rapidly evolving applications in the biotechnology and pharmaceutical industry.

  • Popular / Relevant Prior Art Search Expressions

An examination of IP literature, shortlisting key words and phrases used to describe molecular switches (and affiliated products) that are either already available in the market, or under development. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends.

  • Patent Valuation Analysis

A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region).

  • Patentability and Freedom to Operate

A systematic approach to identifying relevant areas of innovation by analyzing published IP documents (representative of unique patent families), by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP. 

  • Analysis of Patent Applications

A detailed summary of the various patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the  innovation (such as a product class, enabling technologies or method of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends.

  • Analysis of Granted Patents

An analysis of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to molecular switches, and the assessing likelihood for innovators to enter into promising research areas. 

  • Pockets of Innovation and White Spaces

An insightful analysis of the various CPC codes used in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on type of innovation and innovation) in this field of research.

  • Claim Analysis

One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents (representative of unique patent families) in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Contents

DELIVERABLE OUTLINES

Excel Deliverable

Sheet 1 features details regarding how the input data for this project was collated, including the search strings used to query a popular, public patent database (namely lens.org), and data segregation notes. 

Sheet 2 is a summary MS Excel dashboard, offering a detailed, graphical perspective of the intellectual property landscape of molecular switches. It includes pictorial representations of the [A] overall patent landscape, [B] IP documents representing patent families that describe unique innovations related to molecular switches, [C] trends related to patent applications (including insights on patentability and freedom to operate), [D] trends related to granted patents (including insights on patentability and freedom to operate), [E] key inferences from a proprietary claim analysis, [F] list of popular CPC symbols (featuring key pockets of innovation), [G] list of popular applicants (shortlisted based on number of published IP documents).
    
Sheet 3 is an elaborate tabular representation of the overall IP landscape, featuring information on the various types of IP documents, related to molecular switches, which have been published since 1981. 

Sheet 4 is an excerpt of the data presented in the previous sheet, featuring published IP documents, that represent unique patent families across various global jurisdictions. This dataset has been analyzed in detail, in the report. 

Sheet 5 includes a tabular representation of the key words and phrases (prior art search expressions) that are used to describe molecular switches and affiliated intellectual capital.

Sheet 6 is a subset of sheet 4, featuring all the patent applications, covering innovations related to molecular switches and affiliated methods, compositions and engineering techniques.

Sheet 7 is a subset of sheet 4, featuring all the granted patents, covering innovations related to molecular switches and affiliated methods / products. 

Sheet 8 is an insightful summary of key inferences from the independent claims of the granted, active patents in the dataset. It involves the use of a systematic segregation approach to analyze key trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Sheet 9 provides insights related to some of the key applicants that are active in this field of research, featuring company-specific details (such as year of establishment, and location of headquarters), and inputs on their respective IP publication trends. 
    
Sheet 10 features an analysis of the most popular CPC symbols and CPC families (in terms of frequency of appearance in the dataset), related to molecular switches that are either already available in the market, or under development. 

Sheet 11 is an appendix, which includes pivot tables that drive the charts and interactive elements for the complete IP landscape depicted in sheet 2 of the deliverable.

Sheet 12 is an appendix, featuring details related to the categorization done in the report, and important abbreviations used in reference to the data categories mentioned in the document. 

PowerPoint Deliverable
Chapter 1
briefly describes of the need for molecular switches interventions and the key advantages associated with the use of such molecular switches. Further, it provides an overview of the intellectual property landscape related to this niche class of synthetic biology research. 

Chapter 2 and 3 feature brief (pictorial) summaries of the approach used during data collection for this project, and the key objectives of the study.

Chapter 4 is an executive summary of the important insights and key takeaways, generated from analyzing the IP landscape of molecular switches.

Chapter 5 offers an informed perspective on the core concepts of molecular switches. It also includes brief descriptions of molecular switches that are available and under development, elaborating on the contemporary need for such therapeutic and diagnostic solutions. Further, it provides a summary of the important milestones in this field of research, highlighting some of the distinguishing features of both early generation and modern variants of such interventions. The chapter also includes a description of important application areas of molecular switches, highlighting the various advantages and existing limitations of molecular switches.

Chapter 6 includes a review of the various patents and affiliated IP documents that have been published related to molecular switches, since the year 1981. It also features an in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, and includes insightful inferences related to both historical and recent R&D trends within this niche, but rapidly evolving applications the healthcare segment.

Chapter 7 features an insightful examination of IP literature, highlighting key words and phrases that are used to describe different molecular switches, including information on historical usage in IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends.

Chapter 8 offers insights from a competitive benchmarking and valuation analysis of the key members of unique patent families that have been captured in the report. It takes into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region).

Chapter 9 provides a detailed summary of the patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis segregates the captured intellectual capital in terms of type of innovation and the specific innovation (different product classes, enabling technologies or methods of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends. Further, it features an analysis that helps identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), defining the uniqueness of patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 10 is an elaborate summary of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to molecular switches, and assessing the likelihood for innovators to enter into promising product markets, once active patents expire. Further, it features an analysis that helps identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), defining the uniqueness of patented innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 11 features profiles of some of the most popular applicant companies, which were shortlisted based on their respective patent filing activities. Each profiles includes a brief overview of the company, information on annual revenues (wherever available), details on its molecular switch related initiatives, names of key management team members and recent developments. 

Chapter 12 includes an insightful analysis of the various CPC symbols mentioned in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on innovation and innovation types) in this field of research.

Chapter 13 concludes the report by summarizing publicly available insights on the anticipated developments in this domain (taking into consideration the perspectives of eminent representatives of stakeholder companies in this industry), and trends that are likely to shape the future of molecular switches. 

Chapter 14 is a set of appendices, entailing [A] an overview of the excel research report, [B] a list of IP documents featuring the identified white spaces, [C] table of contents, [D] list of figures, [E] list of tables, [F] glossary, and [G] list of all the applicant companies and organizations.

Table Of Contents

Excel Deliverable

1. Research Notes

2. Summary Dashboard
A. Overall Intellectual Property Landscape
B. Intellectual Property Landscape (Grouped by Simple Families)
C. Key Prior Art Search Expressions
D. Key Trends related to Patent Applications (featuring Patentability and Freedom-to-Operate)
E. Key Trends related to Granted Patents (featuring Patentability and Freedom-to-Operate)

F. Claim Analysis
G. Key CPC Symbols
H. Key Applicants

3. Overall Intellectual Property Landscape Dataset

4. Prior Art Search Expressions (Keyword Analysis)

5. Patent Applications Dataset

6. Granted Patents Dataset

7. Claim Analysis

8. Key Applicants Analysis

9. CPC Analysis

10. Appendix I: Pivot Tables

11. Appendix II: Country / Geography Codes

12. Appendix III: Innovation Categories

PowerPoint Deliverable

1. Context

2. Project Approach

3. Project Objectives

4. Executive Summary

5. Molecular switches
5.1. Overview
5.2. Molecules Acting as Molecular Switches
5.3. Applications of Molecular Switches in Healthcare
5.4. Key Advantages and Limitations

6. Overall Intellectual Property Landscape
6.1. Overview
6.2. Analysis of Simple Patent Families
6.3. Key Innovation Categories
6.4. Insights from Patent Applications
6.5. Insights from Granted Patents

7. Key Prior Art Search Expressions
7.1. Overview
7.2. Analysis of Prior Art Search Expressions

8. Intellectual Property Valuation Analysis
8.1. Valuation Overview
8.2. Analysis of Individual Value Ranks
8.2.1. Rank 1 IP Documents
8.2.2. Rank 2 IP Documents
8.2.3. Rank 3 IP Documents
8.2.4. Rank 4 IP Documents
8.2.5. Rank 5 IP Documents
8.3. Concluding Remarks
8.4. List of Rank 1 IP Documents

9. Analysis of Patent Applications
9.1. Overview
9.2. Relative Valuation of Patent Applications
9.3. Patentability & Freedom-to-Operate

10. Analysis of Granted Patents
10.1. Overview
10.2. Relative Valuation of Grated Patents
10.3. Patentability & Freedom-to-Operate
10.4. Analysis of Patent Claims (Granted Active Patents)

11. Key Applicants
11.1. Overview
11.2. Analysis of Key Applicants
11.2.1. Company A
11.2.2. Company B
11.2.3. Company C
11.2.4. Company D
11.2.5. Company E
11.2.6. Company F
11.2.7. Company G
11.2.8. Company H
11.2.9. Company I
11.2.10. Company J

12. Pockets of Innovation and White Spaces
12.1. Overview
12.2. Pockets of Innovation
12.3. White Spaces
12.4. Concluding Remarks

13. Future Outlook
13.1. Molecular Switches: IP Filing Growth Trends
13.2. Relevance of IP for Business Development and Growth
13.3. Contemporary Sentiments and Predictions
13.4 Anticipated Future Developments and Trends

14. Appendices

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. 13therapeutics
  2. 149 Bio
  3. 2seventy bio
  4. 3M
  5. A2 Biotherapeutics
  6. Aarhus University
  7. AB Biosciences
  8. Ab Studio
  9. Abbott
  10. Abbott Laboratories
  11. AbbVie
  12. AbbVie
  13. Abbvie
  14. Accutar Biotech
  15. Aclara Biosciences
  16. Activartis Biotech
  17. Advanced Microbial
  18. AdVec
  19. Advisys
  20. AdynXX
  21. Aeomica
  22. Affigen
  23. Agency for Science, Technology and Research
  24. Agensys
  25. Agensys
  26. Agilent Technologies
  27. AIIMS - All India Institute Of Medical Science
  28. Aix-Marseille University
  29. Aix-Marseille University
  30. Alastin Skincare
  31. Albert Einstein College of Medicine
  32. Alcatel-Lucent Enterprise
  33. Alder BioPharmaceuticals
  34. Alector
  35. Alize Pharma
  36. Allergan
  37. Allinaire Therapeutics
  38. alliumvitalis
  39. Alpha Beta Holdings
  40. Ambion
  41. Amgen
  42. Amicus Therapeutics
  43. Anacor Pharmaceuticals
  44. Anhui Technology
  45. Anhui University of Science and Technology
  46. Antengene Corporation
  47. Applera
  48. Applied Genetic Technologies
  49. Applied Genetics Laboratories
  50. AptaBharat
  51. AptaScan
  52. Araxes Pharma
  53. Arbor Biotechnologies
  54. Archemix
  55. Arena Pharmaceuticals
  56. ARIAD Pharmaceuticals
  57. Aridis Pharmaceuticals
  58. ArQule
  59. Array BioPharma
  60. Asahi Kasei
  61. Ascentage Pharma
  62. Asklepios BioPharmaceutical
  63. ASML
  64. Assistance Publique–Hôpitaux de Paris
  65. Astellas Pharma
  66. Asterias Biotherapeutics
  67. Aston University
  68. AstraZeneca
  69. Athenex
  70. Auburn University
  71. Augusta University Research Institute
  72. Autolus
  73. Aventis Behring
  74. Aventis Pharma
  75. AVEO Pharmaceuticals
  76. Avid Bioservices
  77. Avigen
  78. Axaron Bioscience
  79. Axiogenesis
  80. Axordia
  81. Azeria Therapeutics
  82. Azitra
  83. Babraham Institute
  84. Bach Pharma
  85. Baker Hughes
  86. Bar-Ilan University
  87. BASF
  88. BASF
  89. Bayer
  90. Bayer HealthCare
  91. Bayer Schering Pharma
  92. Baylor College of Medicine
  93. Beida Pharmaceutical Industry
  94. Beijing University of Chemical Technology
  95. Beijing Xuanyi Pharmasciences
  96. Bellastem
  97. Bellicum Pharmaceuticals
  98. Ben-Gurion University of the Negev
  99. BERG
  100. Beth Israel Deaconess Medical Center
  101. BioActa
  102. BIOalternatives
  103. Biogen
  104. Bio-Gene Technologies
  105. BioGlow
  106. BioNTech
  107. BioNTech
  108. Bioquest
  109. BioSante Pharmaceuticals
  110. Biotheryx
  111. Biotraces
  112. BioZyme
  113. Bluebird bio
  114. Bond Pet Foods
  115. Boston Biomedical
  116. Boston Biomedical Research Institute
  117. Boston Medical Center
  118. Boston Probes
  119. Boston Scientific Scimed
  120. Boston University
  121. Brandeis University
  122. Breast Cancer Now
  123. Bridge Pharma
  124. Bridgestone
  125. Brigham and Women's Hospital
  126. Brigham and Women's Hospital
  127. Brilliant Lab
  128. Bristol Myers Squibb
  129. Broad Institute
  130. Brookhaven Science Associates
  131. Brown University
  132. Buck Institute for Research on Aging
  133. Cadus Pharmaceutical
  134. Cadus Technologies
  135. California Institute of Technology
  136. California State University, Northridge
  137. Caliper Life Sciences
  138. Cambridge Scientific
  139. Cambridge University
  140. Cancer Research Technology
  141. Canji
  142. Cara Therapeutics
  143. Cardax Pharmaceuticals
  144. Cardiff University
  145. CareDx
  146. Caribou Biosciences
  147. Carmel
  148. Cartesian Therapeutics
  149. Cartherics
  150. CASCADE BIOSYSTEMS
  151. Case Western Reserve University
  152. Catalan Institution for Research and Advanced Studies
  153. Catalyst Therapeutics
  154. Cathay Biotech
  155. Cathay Biotech
  156. Cava Healthcare
  157. Cedars-Sinai Medical Center
  158. Celdara Medical
  159. Celgene
  160. Cell Genesys
  161. Cell Signaling Technology
  162. Cellectis
  163. Cellex
  164. Celllular Biomedicine Group
  165. Cellular Biomedicine Group
  166. Cellular Therapeutics
  167. Cemvita Factory
  168. Center for Human Reproduction
  169. Centocor
  170. Centre for Drug Research and Development
  171. Centre hospitalier de l'Université de Montréal
  172. Chesapeake Perl
  173. Children’s Medical Center Dallas
  174. Children’s Medical Center Dallas
  175. Children's Healthcare of Atlanta
  176. Children's Hospital of Philadelphia
  177. Children's National Hospital
  178. China Medical University
  179. China Pharmaceutical University
  180. Chinese University of Hong Kong
  181. Chisso
  182. Chosun University
  183. ChromaCon
  184. Chugai Pharmaceutical
  185. Ciba Corning Diagnostics
  186. Citranvi Biosciences
  187. Cleveland State University
  188. CNIC
  189. CNRS
  190. Cochlear
  191. CODA Biotherapeutics
  192. Cognosci
  193. Cognosci
  194. Cold Spring Harbor Laboratory
  195. Columbia University
  196. Columbia University
  197. Commonwealth System of Higher Education
  198. Connecticut Children's Medical Center
  199. Contour Semiconductor
  200. Cornell University
  201. Council of Scientific and Industrial Research
  202. Creative Biomolecules
  203. CropDesign
  204. Crossbar
  205. CrossLife Technologies
  206. CSPC Dophen
  207. CuraGen
  208. Cure Genetics
  209. Curemark
  210. Curie Institute
  211. CZ Biohub
  212. Dade Behring Marburg
  213. Daiichi Sankyo
  214. DAKO
  215. Dalian Institute of Chemical Physics
  216. Dana Farber Cancer Institute
  217. Dana-Farber Cancer Institute
  218. Dana–Farber Cancer Institute
  219. Danisco
  220. Dart NeuroScience
  221. Dartmouth College
  222. Dartmouth College
  223. deCODE genetics
  224. Dendreon Pharmaceuticals
  225. Department of Biotechnology
  226. Detect
  227. Diabetes Free
  228. DONGJIN SEMICHEM
  229. Draper Laboratory
  230. Drexel University
  231. Duke University
  232. DuPont
  233. East Carolina University
  234. East China Normal University
  235. Eastern Michigan University
  236. Eastern Virginia Medical School
  237. Ecole Polytechnique Fédérale de Lausanne
  238. Edge Therapeutics
  239. Edimer Pharmaceuticals
  240. eFFECTOR Therapeutics
  241. Eindhoven University of Technology
  242. EiRx Therapeutics
  243. Electrophoretics
  244. Eleszto Genetika
  245. EMD Serono
  246. Emory University
  247. Empire Dev
  248. Encyt Technologies
  249. Environmental Technologies Group
  250. ESPCI Paris
  251. Eureka Therapeutics
  252. European Molecular Biology Laboratory
  253. Exelixis
  254. Exelixis
  255. EXiBONA
  256. ExxonMobil Chemical
  257. Fate Therapeutics
  258. Feinstein Institutes for Medical Research
  259. Five Prime Therapeutics
  260. Flagship Pioneering
  261. Flagship Pioneering
  262. Flagship Pioneering
  263. Florida State University
  264. FormFactor
  265. Fosun Pharma
  266. Fovea Pharmaceuticals
  267. Fox Chase Cancer Center
  268. Fox Chase Cancer Center
  269. Frankgen Biotechnologie
  270. Fred Hutchinson Cancer Research Center
  271. Fred Hutchinson Cancer Research Center
  272. French Alternative Energies and Atomic Energy Commission
  273. French National Centre for Scientific Research
  274. Fudan University
  275. Fuji Biomedix
  276. Fuji Electric
  277. Fuji Xerox
  278. Fujian Normal Universit
  279. Fujifilm
  280. Fujifilm Cellular Dynamics
  281. Fujitsu
  282. Galactica Pharmaceuticals
  283. GALENAGEN
  284. GalPharma
  285. Gamida Cell
  286. GemVax & KAEL
  287. Gen-9
  288. Genagon Therapeutics
  289. GENEART
  290. Genelabs Technologies
  291. GeneMedicine
  292. Genentech
  293. General Electric
  294. Generation Bio
  295. Genesky Diagnostics
  296. Geneswitch Innovations
  297. GeneTAG Technology
  298. Genethon
  299. Généthon
  300. Genetic Therapy
  301. Genetics Institute
  302. Geneyus
  303. GenFleet Therapeutics
  304. GenFleet Therapeutics
  305. Geniatech
  306. Genizon BioSciences
  307. Genome Therapeutics
  308. GenPath Pharmaceuticals
  309. Gen-Probe
  310. Gen-Probe
  311. Genzyme
  312. Georgetown University
  313. Georgia Regents University
  314. Geron
  315. Gevo
  316. Ghent University
  317. GigaGen
  318. Gladstone Institutes
  319. Gladstone Institutes
  320. Glaxo Group
  321. Glaxo Wellcome SA
  322. Gloriana Therapeutics
  323. Gorilla Genomics
  324. GPB Scientific
  325. GPB Scientific
  326. GPC Biotech
  327. Gracell Biotechnologies
  328. GreenVenus
  329. Grenoble Alpes University
  330. GSK
  331. GSK
  332. Guangdong Institute of Eco-environmental and Soil Sciences
  333. Guangzhou Institute of Biomedicine and Health
  334. Guilin Medical University
  335. Gwangju Institute of Science and Technology
  336. H. Lee Moffitt Cancer Center & Research Institute
  337. Hackensack University Medical Center
  338. Hackensack University Medical Center
  339. Hackensack University Medical Center
  340. Hadasit Medical Research Services & Development
  341. Hangzhou Clongene Biotech
  342. Hangzhou Jiuyuan Gene Engineering
  343. Harbin Veterinary Research Institute
  344. Harbor Therapeutics
  345. Harpoon Therapeutics
  346. Harvard College
  347. Health Research
  348. Helix BioPharma
  349. Henry Ford Health
  350. HEWLETT PACKARD
  351. HEWLETT PACKARD
  352. Hisamitsu Pharmaceutical
  353. Hokkaido University
  354. Hong Kong University of Science and Technology
  355. Hrain Biotechnology
  356. hsfpharma
  357. Huaihai Institute of Technology
  358. Huazhong Agricultural University
  359. Huazhong University of Science and Technology
  360. Human Genome Sciences
  361. Hunan University
  362. Hunan Essence Biotech
  363. IBM
  364. Icahn School of Medicine at Mount Sinai
  365. iCell Gene Therapeutics
  366. iCell Gene Therapeutics
  367. IDEXX Laboratories
  368. ILIAS Biologics
  369. IMDEA Nanociencia
  370. Imiplex
  371. Immetacyte
  372. Immune Disease Institute
  373. ImmuNext
  374. Immunolight
  375. Immunolight
  376. Imperial College London
  377. Incyte
  378. Incyte
  379. Indiana University
  380. Inhibrx
  381. Innate Pharma
  382. InnoCare Pharma
  383. Innovative Targeting Solutions
  384. Inovio Pharmaceuticals
  385. Inserm
  386. Institut Paoli-Calmettes
  387. Institut Pasteur of Shanghai, CAS
  388. Institute Claudius Regaud
  389. Institute of Biophysics
  390. Institute of Cancer Research
  391. Institute of Pharmacology of the Polish Academy of Sciences
  392. Intelligent Medical Devices
  393. Intocell
  394. Intra-Cellular Therapies
  395. Intrexon
  396. Invitrogen
  397. IO Biosciences
  398. iOmx Therapeutics
  399. IONTAS
  400. Ipsen
  401. IRM
  402. IrsiCaixa
  403. Isis Pharmaceuticals
  404. Jackson Laboratory
  405. Jacobio Pharmaceuticals
  406. Janssen Biotech
  407. Janssen Pharmaceutica
  408. Japan Science and Technology Agency
  409. Javelin Oncology
  410. Jawaharlal Nehru Centre for Advanced Scientific Research
  411. Jiangnan University
  412. Jiangsu Police Institute
  413. Jiangxi University of Science and Technology
  414. Jilin University
  415. Jinan University
  416. Johns Hopkins University
  417. Johns Hopkins University School of Medicine 
  418. Johnson & Johnson
  419. Joslin Diabetes Center
  420. Jubilant Biosys
  421. Julius Maximilian University of Würzburg
  422. Juno Therapeutics
  423. Kagawa University
  424. Kaiima
  425. Kansas State University
  426. Kaunas University of Technology
  427. Kazusa DNA Research Institute
  428. Kazusa DNA Research Institute
  429. Keio University
  430. Kent State University
  431. Kindai University
  432. Kinex Pharmaceuticals
  433. King Abdulaziz City for Science and Technology
  434. King Abdulaziz University
  435. King's College London
  436. Kingston University
  437. Kira Pharmaceuticals
  438. Kiromic
  439. Kite Pharma
  440. Knoll
  441. Knowmtech
  442. K?chi University
  443. Konica Minolta
  444. Korea Institute of Science and Technology
  445. Korea Research Institute of Bioscience and Biotechnology
  446. KSQ Therapeutics
  447. KU Leuven
  448. Kumho Petrochemical
  449. Kumquat Biosciences
  450. Kunming Institute of Botany
  451. KWS Saat
  452. Kymab
  453. Kyowa Hakko Kirin
  454. La Jolla Institute for Immunology
  455. LabyRx Immunologic Therapeutics
  456. Larix Bioscience
  457. LECTEC
  458. Leiden University Medical Center
  459. Leidos Biomedical Research
  460. Lek Pharmaceuticals
  461. Lentigen Technology
  462. LG Chem
  463. Life Technologies
  464. London Metropolitan University
  465. Los Alamos National Security
  466. Louisiana State University
  467. Lubris BioPharma
  468. Lucent
  469. Lucidicor
  470. Ludwig Cancer Research
  471. Ludwig Maximilian University of Munich
  472. Lund University
  473. Lundbeck
  474. Lundbeck
  475. Lyell Immunopharma
  476. MacroGenics
  477. Maine Medical Center Research Institute
  478. Marquette University
  479. Martin Luther University of Halle-Wittenberg
  480. Massachusetts Eye and Ear
  481. Massachusetts General Hospital
  482. Massachusetts General Hospital
  483. Massachusetts General Hospital
  484. Massachusetts Institute of Technology
  485. Massachusetts Institute of Technology
  486. Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  487. Max Planck Society
  488. Maxim Pharmaceuticals
  489. Mayo Clinic
  490. McGill University
  491. McMaster University
  492. Medannex
  493. Medical College of Georgia
  494. Medical Research Council
  495. Medigene
  496. Medigene
  497. MedImmune
  498. MediQuest Therapeutics
  499. Medisix Therapeutics
  500. Medvet Science
  501. Memorial Sloan Kettering Cancer Center
  502. Memorial Sloan Kettering Cancer Center
  503. Memorial Sloan Kettering Cancer Center
  504. Merck
  505. Merck
  506. Merical
  507. Meso Scale Discovery
  508. Michigan State University
  509. Micron Technology
  510. Microsoft Technology Licensing
  511. Millennium Pharmaceuticals
  512. Miltenyi Biotec
  513. Miltenyi Biotec
  514. Miraca Life Sciences
  515. Mirati Therapeutics
  516. Mirus Bio
  517. MitoKor
  518. MITRE
  519. Mitsubishi Tanabe Pharma
  520. MMI - Molecular Machines & Industries
  521. Monash University
  522. Monsanto
  523. Morphochem
  524. Motorola
  525. Murdoch Children's Research Institute
  526. MUSC Foundation for Research Development
  527. Myogen
  528. Nagoya University
  529. Nanjing Agricultural University
  530. Nanjing Anji Biological Technology
  531. Nanjing Legend Biotech
  532. NANJING UNIVERSITY
  533. Nanjing University of Science and Technology
  534. Nankai University
  535. Nano Terra
  536. Nanofactory
  537. Nanosys
  538. Nant Holdings
  539. NantCell
  540. Nanyang Technological University
  541. Nara Institute of Science and Technology (NAIST)
  542. NASA
  543. National Agro-Food Biotechnology Institute
  544. National Brain Research Centre (NBRC)
  545. National Center for Nanoscience and Technology
  546. National Dong Hwa University
  547. National Institute of Advanced Industrial Science and Technology
  548. National Institute of Biological Sciences
  549. National Research Council
  550. National Research Council Canada
  551. National Taiwan University
  552. National University of Singapore
  553. National University of Singapore
  554. Nationwide Children's Hospital
  555. NeoNeuro
  556. NeoStem Oncology
  557. New Chapter
  558. New Haven, CT
  559. New York Blood Center
  560. Newcastle Innovation
  561. Newcastle University
  562. NewSouth Innovations
  563. NeXstar Pharmaceuticals
  564. Nissan Chemical
  565. Nitt? Denk?
  566. Northern Illinois University
  567. Northwest Normal University
  568. Northwestern University
  569. NOTOX
  570. Nova Chemicals
  571. Nova Southeastern University
  572. Novagenesis Therapeutix
  573. Novartis
  574. Novartis
  575. Novavax
  576. Novozymes
  577. Novozymes
  578. Nps Pharmaceuticals
  579. NSABP Foundation
  580. NTT Docomo
  581. Nuvelo
  582. Oblique
  583. Obsidian Therapeutics
  584. Ocularis Pharma
  585. Odyssey Thera
  586. Ohio State Innovation Foundation
  587. Ohio State University
  588. Oklahoma Medical Research Foundation
  589. Oklahoma State University–Stillwater
  590. Olivia Newton John Cancer Research Institute
  591. Omega Therapeutics
  592. Oncalis
  593. Oncorus
  594. One Lambda
  595. Opko Health
  596. Oragenics
  597. Oregon Health & Science University
  598. Oregon State University
  599. OriMAbs
  600. Orphazyme
  601. Ortho-McNeil Pharmaceutical
  602. Orum Therapeutics
  603. OSI Pharmaceuticals
  604. Ottawa Hospital Research Institute
  605. Oxford University
  606. Oxitec
  607. Oy Jurilab
  608. PANAGENE
  609. Panomics
  610. Paris Descartes University
  611. Paris-Saclay University
  612. Pennsylvania State University
  613. Peptinovo
  614. PerkinElmer
  615. Perlegen Sciences
  616. Pfizer
  617. Pfizer
  618. Pharmacia & Upjohn
  619. Pharmacyclics
  620. Pharmacyclics
  621. Phenex Pharmaceuticals
  622. Phio Pharmaceuticals
  623. Pinteon Therapeutics
  624. Pioneer Hi Bred International
  625. Pivot Bio
  626. Plant Bioscience
  627. Plasma Antennas
  628. PolyGene
  629. Pompeu Fabra University
  630. Precigen
  631. Precigen
  632. Precision BioSciences
  633. Premium Genetics
  634. Princeton University
  635. Promega
  636. QIMR Berghofer Medical Research Institute
  637. Qingdao Institute of Bioenergy and Bioprocess Technology
  638. Qingdao University
  639. Qingdao University of Science and Technology
  640. Qtg Development
  641. Quantum Precision Instruments
  642. Quantum-Si
  643. Ramot
  644. Rational Affinity Devices
  645. Raytheon BBN
  646. Regen BioPharma
  647. Regeneron Pharmaceuticals
  648. Regenertech
  649. Regenesis Biomedical
  650. Regents of the University of Colorado
  651. REGENXBIO
  652. Research Center for Eco-Environmental Sciences
  653. Research Institute of the McGill University Health Centre
  654. Responsif
  655. Rhodes University
  656. Ribozyme Pharmaceuticals
  657. Rice University
  658. Rice University
  659. Rigel Pharmaceuticals
  660. Roche
  661. Rochester Institute of Technology
  662. Rockefeller University
  663. Rohm and Haas
  664. Roma Tre University
  665. Roswell Biotechnologies
  666. Rubius Therapeutics
  667. Ruhr University Bochum
  668. Rush University Medical Center
  669. Saint Louis University
  670. Saitama Medical University
  671. Salk Institute for Biological Studies
  672. Samaritan Pharmaceuticals
  673. Samsung
  674. Samumed
  675. Sana Biotechnology
  676. Sandia National Laboratories
  677. Sandoz
  678. Sanford Burnham Prebys
  679. Sanford Burnham Prebys Medical Discovery Institute
  680. Sangamo Therapeutics
  681. Sangamo Therapeutics
  682. Sanofi
  683. Sanofi
  684. Santen
  685. Sapienza University of Rome
  686. Schering
  687. Schering-Plough
  688. Scripps Research Institute
  689. Seattle Children’s Research Institute
  690. Senomyx
  691. Sensei Biotherapeutics
  692. Senti Bio
  693. Seoul Electronics & Telecom
  694. Seoul National University
  695. Serono Genetics Institute
  696. Shandong Agricultural University
  697. Shanghai Cell Therapy Group
  698. Shanghai Institute of Nutrition and Health
  699. Shanghai Jiao Tong University
  700. Shanghai University of Electric Power
  701. Shanxi Agricultural University
  702. Shaoyang University
  703. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS
  704. Shimadzu
  705. Sibelius
  706. Sichuan Huiyu Pharmaceutical
  707. Signase
  708. Sino Biological
  709. SIRION Biotech
  710. SKM PHARMA
  711. Skolkovo Institute of Science and Technology
  712. Snap Bio
  713. SONY
  714. Soochow University
  715. South China Agricultural University
  716. South China Normal University
  717. South Eastern Sydney Local Health District SESLHD
  718. Southeast University
  719. Southern Illinois University
  720. Southern Methodist University
  721. SpeeDx
  722. St. Jude Children's Research Hospital
  723. St. Jude Children's Research Hospital
  724. St. Michael’s Hospital
  725. Staidson Beijing Biopharmaceuticals
  726. Stanford Research Institute
  727. Stanford University
  728. State University of New York
  729. STMicroelectronics
  730. STX-Aprilis
  731. Sulzer
  732. Sumitomo Pharma Oncology
  733. Summit
  734. Sungkyunkwan University
  735. SunTracker Technologies
  736. Sure Erasure
  737. Suzhou University
  738. SwanBio Therapeutics
  739. Switch Bio
  740. SWITCH Materials
  741. Symphogen
  742. Syngenta
  743. Synlogic
  744. Synpromics
  745. Syracuse University
  746. SYZ Cell Therapy
  747. Taizhou Vocational & Technical College
  748. Targeted Genetics
  749. TCR2 Therapeutics
  750. Technical University of Munich
  751. Technicon Instruments
  752. Technion – Israel Institute of Technology
  753. Temasek Life Sciences Laboratory
  754. Temple University
  755. Texas A&M University
  756. Texas Biomedical Research Institute
  757. The Institute of Cancer Research
  758. The Leibniz Institute on Aging – Fritz Lipmann Institute
  759. The Wistar Institute
  760. Theodor Kocher Institute
  761. Theras
  762. Thomas Jefferson University
  763. Thsti - Translational Health Science and Technology Institute
  764. Tianjin Anbisen Biology Technology
  765. Tianjin Hengda Wenbo Science and Technology
  766. Tianma Microelectronics
  767. Tidal Therapeutics
  768. Tissuemed
  769. Tmunity Therapeutics
  770. Tolero Pharmaceuticals
  771. TOLREMO therapeutics
  772. Tosk
  773. Toulouse III - Paul Sabatier University
  774. Toulouse III - Paul Sabatier University
  775. Transimmune
  776. Translate Bio
  777. Translational Genomics Research Institute
  778. Transoft Solutions
  779. TransTech Pharma
  780. Trinity College Dublin
  781. Trishula Therapeutics
  782. TRON Translational Oncology
  783. TRT Pharma
  784. Tsinghua University
  785. Tufts University
  786. Tularik
  787. U. S. Genomics
  788. U.S. Department of Health and Human Services
  789. UBE
  790. UCB Biopharma
  791. UCL Business
  792. UCLA
  793. UEA Enterprises
  794. United Arab Emirates University
  795. United States Department of Agriculture
  796. United States Department of Veterans Affairs
  797. Universal Sequencing Technology
  798. Universitat Autònoma de Barcelona
  799. University Clinic Freiburg
  800. University College Cork
  801. University Health Network
  802. University Medical Center Schleswig-Holstein
  803. University of Aberdeen
  804. University of Alberta
  805. University of Angers
  806. University of Arizona
  807. University of Arizona
  808. University of Arkansas
  809. University of Basel
  810. University of Bonn
  811. University of Bordeaux
  812. University of Bradford
  813. University of British Columbia
  814. University of Brussels
  815. University of California
  816. University of California San Diego
  817. University of Cambridge
  818. University of Central Florida
  819. University of Chicago
  820. University of Cologne
  821. University of Cologne
  822. University of Colorado
  823. University of Colorado
  824. University of Copenhagen
  825. University of Delaware
  826. University of Duisburg-Essen
  827. University of Erlangen–Nuremberg
  828. University of Florida
  829. University of Florida
  830. University of Freiburg
  831. University of Geneva
  832. University of Georgia
  833. University of Heidelberg
  834. University of Helsinki
  835. University of Hong Kong
  836. University of Houston
  837. University of Illinois
  838. University of Iowa Research Foundation
  839. University of Iowa Research Foundation
  840. University of Jena
  841. University of Kentucky
  842. University of Konstanz
  843. University of Louisville
  844. University of Magdeburg
  845. University of Manchester
  846. University of Manitoba
  847. University of Maryland
  848. University of Massachusetts
  849. University of Miami
  850. University of Michigan
  851. University of Michigan
  852. University of Milano-Bicocca
  853. University of Minnesota
  854. University of Missouri
  855. University of Montpellier
  856. University of Montreal
  857. University of Münster
  858. University of Nantes
  859. University of Naples Federico II
  860. University of New York
  861. University of North Carolina
  862. University of North Carolina at Chapel Hill
  863. University of North Carolina at Charlotte
  864. University of Notre Dame
  865. University of Oslo
  866. University of Ottawa
  867. University of Oxford
  868. University of Pennsylvania
  869. University of Pennsylvania
  870. University of Pennsylvania
  871. University of Pittsburgh
  872. University of Pittsburgh
  873. University of Poitiers
  874. University of Portsmouth
  875. University of Puerto Rico
  876. University of Queensland
  877. University of Regensburg
  878. University of Rennes 1
  879. University of Rochester
  880. University of Rome Tor Vergata
  881. University of Saskatchewan
  882. University of Sheffield
  883. University of South Carolina
  884. University of South Dakota
  885. University of South Florida
  886. University of Southern California
  887. University of Southwest
  888. University of Stanford
  889. University of Stuttgart
  890. University of Sussex
  891. University of Texas
  892. University of the Witwatersrand
  893. University of Tokyo
  894. University of Toyama
  895. University of Tübingen
  896. University of Utah
  897. University of Utah
  898. University of Vermont
  899. University of Verona
  900. University of Virginia
  901. University of Washington
  902. University of Washington
  903. University of Wyoming
  904. University of York
  905. University of Zurich
  906. University Research Corp
  907. University of Toledo
  908. UNM Rainforest Innovations
  909. Upjohn
  910. URIFER
  911. Utah State University
  912. Valentis
  913. Valio
  914. Vanderbilt University
  915. VastCon
  916. Vegenics
  917. Ventana Medical Systems
  918. Verastem
  919. Verily Life Sciences
  920. Vernalis
  921. VEROVACCiNES
  922. Vestion
  923. Vgx Pharmaceuticals
  924. Vgx Pharmaceuticals
  925. Vidya Herbs
  926. Virginia Tech
  927. Virginia Tech Intellectual Properties
  928. ViroMed
  929. Vlaams Institute of Biotechnology
  930. Voronoi
  931. VORONOI
  932. Voyager Therapeutics
  933. Wake Forest University
  934. Walter and Eliza Hall Institute of Medical Research
  935. Warner–Lambert
  936. Wayne State University
  937. Whitehead Institute
  938. WindMIL Therapeutics
  939. Wisconsin Alumni Research Foundation
  940. WisTa Laboratories
  941. Wistar Institute
  942. WiSys
  943. Wuhan HealthCare Biotechnology
  944. WuXi Biologics
  945. Wyeth
  946. Wyeth
  947. Xenogen
  948. Xiamen University
  949. Xi'an University of Science and Technology
  950. Xilinx
  951. Xuanwu Hospital Capital Medical University
  952. Yale University
  953. YEDA
  954. YEDA
  955. Yeditepe University
  956. Yissum
  957. Zeneca
  958. Zhejiang Academy of Agricultural Sciences
  959. Zhejiang University
  960. ZymoGenetics
  961. ZyngeniaSalix Pharmaceuticals

PRICING DETAILS

USD 1,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com